Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Exchange Rate Effect (2017 - 2022)

Protagonist Therapeutics' Exchange Rate Effect history spans 6 years, with the latest figure at $75000.0 for Q4 2022.

  • For Q4 2022, Exchange Rate Effect rose 240.91% year-over-year to $75000.0; the TTM value through Dec 2022 reached -$90000.0, up 28.57%, while the annual FY2022 figure was -$90000.0, 28.57% up from the prior year.
  • Exchange Rate Effect for Q4 2022 was $75000.0 at Protagonist Therapeutics, up from -$175000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $123000.0 in Q3 2020 and bottomed at -$175000.0 in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$14000.0 (2019), against an average of -$14666.7.
  • The largest YoY upside for Exchange Rate Effect was 1244.44% in 2020 against a maximum downside of 1000.0% in 2020.
  • A 5-year view of Exchange Rate Effect shows it stood at -$87000.0 in 2018, then tumbled by 43.68% to -$125000.0 in 2019, then soared by 116.8% to $21000.0 in 2020, then increased by 4.76% to $22000.0 in 2021, then surged by 240.91% to $75000.0 in 2022.
  • Per Business Quant, the three most recent readings for PTGX's Exchange Rate Effect are $75000.0 (Q4 2022), -$175000.0 (Q3 2022), and -$19000.0 (Q2 2022).